Latest Articles

IFUS is a sleeper stock just starting to get traction. It's a technology company not a product company where you would traditionally want to look at sales figures.

Stocks covered in this article include CASI, JMIA, SOUN, CORZ, OPTT, ASTS, CHPT, MVIS, STEM, LCID, CVNA, ROOT, CTRN, SBUX, WYNN, DIS, NKE, CRK, SPY, QQQ, DIA, IWM, DJT, SCNI.

GLP-1 companies like Novo Nordisk’s (NYSE: NOVO) Ozempic and Eli Lilly’s (NYSE: LLY) Mounjaro are creating a whole new market opportunity we call the protein trade. A number of stocks are slated to benefit from the protein trade as people try to avoid Ozempic face.

Insider Financial recaps the day's small-cap action and covers the top stocks on our radar.

BitMine Immersion Technologies (OTCMKTS: BMNR) stands out from the pack of Bitcoin stocks in terms of value, technology, and efficiency.

The threat of Bird Flu has been percolating for the past 2 months. Here are the biotech stocks to play this trade.

In this article, Insider Financial recaps the day's small action action and looks at the meme stocks on our radar.

The main themes driving current market trends are AI-powered chips by Nvidia (NASDAQ: NVDA) and the booming diabetes market, particularly driven by GLP-1 obesity drugs. Novo Nordisk’s (NYSE: NOVO) Ozempic and Eli Lilly’s (NYSE: LLY) Mounjaro are leading, but face capacity issues and muscle mass loss concerns. This opens opportunities for new therapeutic solutions, with big pharma companies like Sanofi Adventis (NYSE: SNY) making significant investments, such as acquiring ProventionBio, Inc. for $2.9 billion. Key biotechs exploring novel diabetes treatments include: 1. Fractyl Health (NASDAQ: GUTS) - Developing gene therapy to manage blood sugar without daily insulin, showing promising results in animal trials. 2. Vertex Pharmaceuticals (NASDAQ: VRTX) - Pursuing stem cell-derived insulin-producing islet cell therapies, aiming for a one-time functional cure, despite ethical and trial challenges. 3. Sernova Corp (OTCMKTS: SEOVF) - Innovating with a cell pouch device for placing donor or stem cell-derived islets, demonstrating high efficacy in trials and strong partnerships with companies like Evotec (NASDAQ: EVO). Investment potential varies, with Sernova standing out due to proven clinical success, scalable technology, and strategic alliances, making it a compelling choice in the diabetes treatment market.

Insider Financial recaps the day's small-cap action and covers the stocks on our radar screen.

Insider Financial summarizes the investment thesis surrounding Anavex Life Sciences (NASDAQ: AVXL).

Insider Financial recaps the day's small cap action and covers the stocks on our radar screen.

In this article, we outline what we believe is truly a hidden gem in a new public company called Catheter Precision (NYSE: VTAK).